Intermediate- to high-risk prostate cancer patient treated with radiation therapy.
Crawford
E David
ED
University of Colorado Health Sciences Center, Denver, USA.
Barqawi
Al
A
D018931:Antineoplastic Agents, Hormonal; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D010347:Patient Care Planning; D017430:Prostate-Specific Antigen; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000532:radiotherapy*; D011832:Radiation Injuries; D012307:Risk Factors
D018931:Antineoplastic Agents, Hormonal; D017430:Prostate-Specific Antigen